Rathod Akshay Maroti, Kasumbiwal Ajay H., Lakhe Siddheshwar A, Mundhe Sudarshan R
This license
enables reusers to distribute, remix, adapt, and build upon the material in any
medium or format for noncommercial purposes only, and only so long as
attribution is given to the creator.
Dr. Gagandeep Kang, one of India’s leading medical scientists, has made transformative contributions to pediatric healthcare, particularly in the field of infectious diseases. Widely known as India’s “vaccine godmother,” she played a pivotal role in the development, clinical trials, and national introduction of the indigenous rotavirus vaccine, Rotavac, significantly reducing childhood diarrheal deaths. Born in Shimla in 1962, and trained at Christian Medical College, Vellore, she built her career around understanding and combating enteric infections affecting underserved children. Her research spans mucosal immunology, gut health, nutrition, and large-scale disease surveillance. Despite challenges such as gender bias, limited resources, and ethical complexities in pediatric trials, Dr. Kang’s perseverance and leadership set new standards for scientific rigor and public health impact in India. As the first Indian woman Fellow of the Royal Society and a globally respected researcher, she exemplifies the integration of scientific innovation, empathy, and ethical responsibility. Her life offers powerful lessons for students on curiosity, collaboration, resilience, and service-oriented science.
Kasumbiwal Ajay H., Lakhe Siddheshwar A., Mundhe Sudarshan R. et al. The Contribution of Dr. Gagandeep Kang to the Field of Pediatrics. Pediatr. Edu. Res. 2025; 13(2): 155-157.
This license
enables reusers to distribute, remix, adapt, and build upon the material in any
medium or format for noncommercial purposes only, and only so long as
attribution is given to the creator.
| Received | Accepted | Published |
|---|---|---|
| December 02, 2025 | January 05, 2026 | December 30, 2025 |
Sunday 21 June 2026, 15:43:54 (IST)
Download citation
Highlight selected keywords in the article text.
| Received | December 02, 2025 |
| Accepted | January 05, 2026 |
| Published | December 30, 2025 |
This license
enables reusers to distribute, remix, adapt, and build upon the material in any
medium or format for noncommercial purposes only, and only so long as
attribution is given to the creator.